Ayana Pharma is uniquely positioned to expand the uses and efficacy of the lipid-based cytotoxic drug’s well-established clinical profile. Invented by Prof. Yechezkel Barenholtz from the Hebrew University who is also the co-founder of Ayana Pharma.
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The Company has an innovative and broad pipeline of product candidates that it believes can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology.
We are a clinical-stage pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies using our transformational PLEX (Polymer-Lipid Encapsulation matriX) technology. The Company’s product pipeline candidates are designed to address unmet medical needs by pairing PLEX technology with approved pharmaceuticals which are delivered locally at predetermined release rates and durations over periods ranging from days to several months.
Rotem, a longtime world leader in consumables for PET imaging, supplies cyclotrons around the world with complete packages for radiotracer production. Our product line is centered on Oxygen-18 enriched water, plastic cassettes, precursors and full reagent kits for various synthesis modules
Isorad Ltd. was established 40 years ago, in order to commercialize technologies which have been developed in the SOREQ Nuclear Research Center (Soreq NRC) near Yavne, Israel. Over the years, Isorad has been involved in the following areas: Electro optical elements, Lasers, Fuel Chemical Tagging, Radiation Detection, Wind Measurement and many more
ELGAN Pharma is a late-stage neonatology-focused biotechnology company, lead indication going into second phase III multinational trial with pipeline of high unmet needs of premature infants.
The company is dedicated to developing safe tailored therapies to address medical problems and developmental difficulties that are common in babies born very early.
